Postscripts Rx
Claim This Podcastby PostScripts Rx Team
Podcast Overview
<p><b>Conversations Beyond the Prescription. </b>Where pharma, HCPs, life science and digital health solutions meets patients—after the script is written. Conversations on digital health, engagement, and real-world impacts that are re-writing the future of patient engagement.</p>
Language
🇺🇲
Publishing Since
8/8/2025
Reach the team behind Postscripts Rx
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
October 15, 2025
When MFN Pricing Meets Patient Power: How Digital Support Becomes the Moat
Prices are leveling, but the real story is where competitive edge is moving: from rebates and discounts to experience, trust, and the moments that keep a patient on therapy. We dig into the MFN pricing model and its ripple effects across U.S. pharma, explaining how reference-based pricing compresses margins and forces brands to compete on loyalty, adherence, and the quality of their support programs. When physicians and patients see real-time costs at the point of prescribing, “comparable” op...
October 14, 2025
PBMs, Transparency, and the D2C Pivot
Prices that used to hide in the shadows are stepping into the light—and it’s changing how patients get their medicines. We dive deep into the PBM reckoning: why scrutiny is mounting, how California’s new law opens the books on rebates and reimbursements, and what more than 30 states signal for the future of drug access. From there, we chart the path pharma is taking to meet the moment—standing up direct-to-consumer channels, publishing clear cash prices for GLP-1s and insulin, and using digit...
October 1, 2025
Inside Pfizer’s Bold Bet on Direct-to-Consumer Drug Sales—and What It Means for Access, Pricing, and Power
A pharmaceutical giant just pressed the D2C button—and the ripple effects could reset how Americans find, pay for, and receive their medications. We unpack Pfizer’s move to list discounted drugs on TrumpRX, why visible pricing matters to patients skipping doses due to cost, and how a retail-like experience collides with the realities of safety, compliance, and payer rules. The story isn’t just about cheaper price tags; it’s about whether pharma can deliver trust, guidance, and continuity when...
38 total episodes available
Deep-dive analytics for Postscripts Rx
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Postscripts Rx?
<p><b>Conversations Beyond the Prescription. </b>Where pharma, HCPs, life science and digital health solutions meets patients—after the script is written. Conversations on digital health, engagement, and real-world impacts that are re-writing the future of patient engagement.</p> - How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.